BLTEBelite Bio, Inc
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Rangebound, no clear trend. Price is −8% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Lightly shorted, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How BLTE is trading
Belite Bio, Inc is +66% over the past year while the S&P 500 is +16%: 50 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −7.9%
vs 200-day average · below trend, but not far
- RSI (14)
- 39
RSI (14) · neutral
- Below its 52-week high
- 24%
Below its 52-week high
Details›
- Last close2026-10-23
- $147.90
- 1 monthS&P 500 −0.94%
- −13%
- 1 yearS&P 500 +16%
- +66%
- vs 50-day average$163.16
- −9.3%
- 52-week high
- $193.66
- 52-week low
- $87.71
- Annualised volatility
- 55%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $2.9M
| Year | Return |
|---|---|
| 2026 (year to date) | −7.5% |
| 2025 | +154% |
| 2024 | +38% |
| 2023 | +52% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 4 | 1 of 4 | −2.1% |
| Feb | 4 | 3 of 4 | +7.1% |
| Mar | 4 | 1 of 4 | −6.8% |
| Apr | 4 | 1 of 4 | −1.2% |
| May | 5 | 3 of 5 | +3.3% |
| Jun | 5 | 2 of 5 | +16% |
| Jul | 5 | 5 of 5 | +19% |
| Aug | 5 | 1 of 5 | +7.7% |
| Sep | 5 | 3 of 5 | +4.2% |
| Oct | 5 | 3 of 5 | +15% |
| Nov | 4 | 3 of 4 | +12% |
| Dec | 4 | 2 of 4 | +4.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.